Skip to main navigation

HOME
ABOUT ENZON
ROYALTY PRODUCTS
INVESTORS & MEDIA
Investor Relations
CONTACT US

Request Information
Email Alerts
Download Library
RSS News Feeds

Shareholder Tools

Downloads

Print

Downloads

Categories

Year

Oct 29, 2010

Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting 11.8 KB

Oct 29, 2010

CORRECTING and REPLACING Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting 12.3 KB

Oct 26, 2010

Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010 9.1 KB

Oct 05, 2010

Finance and Audit Committee Charter 53.1 KB

Oct 05, 2010

Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediatric Neuroblastoma 16.5 KB

Aug 03, 2010

Enzon Reports Second Quarter 2010 Results 30.9 KB

Jul 28, 2010

Enzon to Release Second Quarter 2010 Earnings on Tuesday, August 3, 2010; Conference Call and Webcast to Follow 10.6 KB

Jun 30, 2010

2010 Revised Proxy Statement 195.6 KB

Jun 10, 2010

2010 Proxy Statement 431.3 KB

May 10, 2010

Enzon Reports 1st Quarter 2010 Results 34.4 KB

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

©2023 Enzon Pharmaceuticals, Inc., All Rights Reserved.